The Disguised Difference · Research quality
U.S.-Lyophilized Research Peptides
Disguised Alpha uses U.S. lyophilization for the majority of its lyophilized peptide catalog, with product-specific exceptions. Domestic lyophilization describes the freeze-drying stage. Researchers should evaluate the manufacturing scope together with the exact product, batch identifier and analytical report.
The domestic processing step
Our approach brings domestic lyophilization, GMP manufacturing practices and chain-of-custody testing into the quality conversation. Each addresses a different question: where processing occurs, how work is controlled, and how a sample connects to its results. A location statement alone cannot answer all three.
Which products does the statement cover?
The scope is lyophilized peptide products. Capsules, sprays, liquids, creams and other formats have their own production pathways. There are also exceptions within the peptide catalog. Request confirmation for the exact product and batch when domestic processing is part of your procurement criteria.
What belongs in a purchasing record?
Keep the product name, selected size, supplier batch number and original laboratory report together. If a U.S. processing statement is required for a project, retain the written clarification of the operation it covers. Shipping from the United States and freeze-drying in the United States describe different activities.
Common questions
Are all Disguised Alpha products lyophilized in the United States?
No. The domestic lyophilization statement concerns the majority of the lyophilized peptide catalog and has product-specific exceptions. Other product formats should be evaluated separately.
Does U.S. lyophilization establish the origin of the raw material?
No. Raw-material origin and the location of freeze-drying are separate facts. Ask for the specific origin information required by your project.
